The main objective of this study is to assess the impact of two different doses of a mixture of probiotics from two strains isolated in human milk on the incidence of severe necrotizing enterocolitis (NEC) and death among preterm infants of gestational age less than or equal to 32 weeks of gestation and weighing between 750 and 1500 g.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
583
A daily high dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x109 CFU of each of the strains
A daily low dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x106 CFU of each of the strains
Hospital Virgen de las Nieves
Granada, Spain
Incidence of necrotizing enterocolitis and all-cause mortality
The primary objective of the study was to determine the incidence of necrotizing enterocolitis (modified Bell classification stages II and III) and all-cause mortality during hospital stay in both intervention groups.
Time frame: From birth until three months
Intestinal colonization by administered strains
Time frame: From birth until three months
Incidence of Late Onset Sepsis
Incidence of Late Onset Sepsis. In accordance with the criteria used by the Castrillo Group for neonatal infections in Spain (compatible clinical symptoms, elevation of water-phase reactants and positive blood culture)
Time frame: From birth until three months
Time to complete enteral nutrition
Time to reach complete enteral nutrition 140 ml/kg/day
Time frame: From birth until three months
Days of Central Vascular Catheter
Time frame: From birth until three months
Length of hospital stay
Days of hospital stay
Time frame: From birth until three months
Weight change
Time frame: From birth until three months
Incidence of Bronchopulmonary Dysplasia
Time frame: From birth until three months
Incidence of patent ductus arteriosus
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: From birth until three months